ATXS
NASDAQAstria Therapeutics Inc.
$12.56+0.07 (+0.56%)
News25/Ratings7
Price$12.56+0.41 (+3.37%)
2025-10-202026-01-23
News · 26 weeks600%
2025-10-262026-04-19
Mix1190d
- SEC Filings6(55%)
- Other5(45%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by Astria Therapeutics Inc.SCHEDULE 13G/A - Astria Therapeutics, Inc. (0001454789) (Subject)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Astria Therapeutics Inc.SCHEDULE 13D/A - Astria Therapeutics, Inc. (0001454789) (Subject)
- SECSEC Form 15-12G filed by Astria Therapeutics Inc.15-12G - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Astria Therapeutics Inc.SCHEDULE 13D/A - Astria Therapeutics, Inc. (0001454789) (Subject)
- SECSEC Form EFFECT filed by Astria Therapeutics Inc.EFFECT - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form EFFECT filed by Astria Therapeutics Inc.EFFECT - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form EFFECT filed by Astria Therapeutics Inc.EFFECT - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form EFFECT filed by Astria Therapeutics Inc.EFFECT - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form EFFECT filed by Astria Therapeutics Inc.EFFECT - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form EFFECT filed by Astria Therapeutics Inc.EFFECT - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECAmendment: SEC Form 25-NSE/A filed by Astria Therapeutics Inc.25-NSE/A - Astria Therapeutics, Inc. (0001454789) (Subject)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- SECSEC Form S-8 POS filed by Astria Therapeutics Inc.S-8 POS - Astria Therapeutics, Inc. (0001454789) (Filer)
- INSIDERDirector Violin Jonathan returned 263,321 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
- INSIDERSEC Form 4 filed by Chief Medical Officer Morabito Christopher4 - Astria Therapeutics, Inc. (0001454789) (Issuer)